Literature DB >> 25773392

The role of tumor suppressor gene SOX11 in prostate cancer.

Zhiyong Yao1, Bin Sun, Quan Hong, Jingmin Yan, Dawei Mu, Jianye Li, Haibo Sheng, Heqing Guo.   

Abstract

SOX genes play an important role in a number of developmental processes. The transcription factor SOX11 is one of the members of the SOX family emerging as important transcriptional regulators. The aim of this study was to investigate the role of SOX11 in prostate cancer (PCa) and its expression pattern and clinical significance. The gene expression of SOX11 in human PCa tissues compared with benign prostate hyperplasia (BPH) tissues was detected using real-time quantitative reverse transcriptase-polymerase chain reaction (QRT-PCR) analysis and immunohositochemistry. SOX11 overexpression cell model was used to examine the role of SOX11 in cell growth and metastasis in vitro. The results showed that the positive rate of SOX11 staining was 16.67 % (10/60) in cases of prostatic carcinoma and 81.67 % (49/60) in cases of BPH, and the difference of SOX11 expression between PCa and BPH was statistically significant (P < 0.001). SOX11 mRNA level was lowly expressed in PCa cell lines compared to RWPE-1. SOX11 overexpression suppresses PCa cell migration and invasion. In conclusion, our findings demonstrate that SOX11 could suppress cell proliferation, migration, and invasion of PCa in vitro.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25773392     DOI: 10.1007/s13277-015-3296-3

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  17 in total

Review 1.  The complex landscape of genetic alterations in mantle cell lymphoma.

Authors:  Cristina Royo; Itziar Salaverria; Elena M Hartmann; Andreas Rosenwald; Elías Campo; Sílvia Beà
Journal:  Semin Cancer Biol       Date:  2011-09-18       Impact factor: 15.707

2.  EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.

Authors:  Axel Heidenreich; Joaquim Bellmunt; Michel Bolla; Steven Joniau; Malcolm Mason; Vsevolod Matveev; Nicolas Mottet; Hans-Peter Schmid; Theo van der Kwast; Thomas Wiegel; Filliberto Zattoni
Journal:  Eur Urol       Date:  2010-10-28       Impact factor: 20.096

3.  SRY-box containing gene 11 (Sox11) transcription factor is required for neuron survival and neurite growth.

Authors:  M P Jankowski; P K Cornuet; S McIlwrath; H R Koerber; K M Albers
Journal:  Neuroscience       Date:  2006-10-19       Impact factor: 3.590

4.  Estimates of cancer incidence and mortality in Europe in 2008.

Authors:  J Ferlay; D M Parkin; E Steliarova-Foucher
Journal:  Eur J Cancer       Date:  2010-01-29       Impact factor: 9.162

5.  Expression of the Sox11 gene in mouse embryos suggests roles in neuronal maturation and epithelio-mesenchymal induction.

Authors:  M Hargrave; E Wright; J Kun; J Emery; L Cooper; P Koopman
Journal:  Dev Dyn       Date:  1997-10       Impact factor: 3.780

6.  Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression.

Authors:  Weifen Zeng; Kai Fu; Leticia Quintanilla-Fend; Megan Lim; Sarah Ondrejka; Eric D Hsi
Journal:  Am J Surg Pathol       Date:  2012-02       Impact factor: 6.394

7.  Gene targeting reveals a widespread role for the high-mobility-group transcription factor Sox11 in tissue remodeling.

Authors:  Elisabeth Sock; Stefanie D Rettig; Janna Enderich; Michael R Bösl; Ernst R Tamm; Michael Wegner
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

8.  SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies.

Authors:  Elin Gustavsson; Sandra Sernbo; Elin Andersson; Donal J Brennan; Michael Dictor; Mats Jerkeman; Carl Ak Borrebaeck; Sara Ek
Journal:  Mol Cancer       Date:  2010-07-12       Impact factor: 27.401

9.  BMP signaling is required for septation of the outflow tract of the mammalian heart.

Authors:  Emmanuèle C Délot; Matthew E Bahamonde; Manxu Zhao; Karen M Lyons
Journal:  Development       Date:  2003-01       Impact factor: 6.868

10.  Sox11 expression in astrocytic gliomas: correlation with nestin/c-Met/IDH1-R132H expression phenotypes, p-Stat-3 and survival.

Authors:  P Korkolopoulou; G Levidou; E A El-Habr; C Adamopoulos; P Fragkou; E Boviatsis; M S Themistocleous; K Petraki; G Vrettakos; M Sakalidou; V Samaras; A Zisakis; A Saetta; I Chatziandreou; E Patsouris; C Piperi
Journal:  Br J Cancer       Date:  2013-04-25       Impact factor: 7.640

View more
  9 in total

1.  Promoter hypermethylation of SOX11 correlates with adverse clinicopathological features of human prostate cancer.

Authors:  Apiwat Pugongchai; Andrey Bychkov; Pichet Sampatanukul
Journal:  Int J Exp Pathol       Date:  2018-01-08       Impact factor: 1.925

2.  SOX11 hypermethylation as a tumor biomarker in endometrial cancer.

Authors:  Tianjiao Shan; Denise S Uyar; Li-Shu Wang; David G Mutch; Tim H-M Huang; Janet S Rader; Xiugui Sheng; Yi-Wen Huang
Journal:  Biochimie       Date:  2019-03-29       Impact factor: 4.079

3.  Overexpression miR-211-5p hinders the proliferation, migration, and invasion of thyroid tumor cells by downregulating SOX11.

Authors:  Lei Wang; Yan-Feng Shen; Zhi-Min Shi; Xiao-Juan Shang; Dong-Ling Jin; Feng Xi
Journal:  J Clin Lab Anal       Date:  2017-07-13       Impact factor: 2.352

4.  Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma.

Authors:  Atish Mohanty; Natalie Sandoval; An Phan; Thang V Nguyen; Robert W Chen; Elizabeth Budde; Matthew Mei; Leslie Popplewell; Lan V Pham; Larry W Kwak; Dennis D Weisenburger; Steven T Rosen; Wing C Chan; Markus Müschen; Vu N Ngo
Journal:  Blood       Date:  2018-12-10       Impact factor: 25.476

5.  SOX11 promotes invasive growth and ductal carcinoma in situ progression.

Authors:  Erik Oliemuller; Naoko Kogata; Philip Bland; Divya Kriplani; Frances Daley; Syed Haider; Vandna Shah; Elinor J Sawyer; Beatrice A Howard
Journal:  J Pathol       Date:  2017-08-22       Impact factor: 7.996

6.  Sex-determining region Y box-containing genes: regulators and biomarkers in gynecological cancers.

Authors:  Jiali Hu; Ke Li; Zhanghuan Li; Chao Gao; Fei Guo; Yingmei Wang; Fengxia Xue
Journal:  Cancer Biol Med       Date:  2019-08       Impact factor: 4.248

7.  SOX8 Knockdown Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer by Inhibiting the Notch Signaling Pathway.

Authors:  Zhongbo Du; Xiaobin Chen; Pingyu Zhu; Wei Sun; Qi Lv; Shulin Cheng; Xuesong Yang; Xiaodong Yu
Journal:  Biomed Res Int       Date:  2022-10-06       Impact factor: 3.246

8.  Upregulation of SOX11 enhances tamoxifen resistance and promotes epithelial-to-mesenchymal transition via slug in MCF-7 breast cancer cells.

Authors:  Yingsheng Xiao; Qin Xie; Qingsong Qin; Yuanke Liang; Haoyu Lin
Journal:  J Cell Physiol       Date:  2020-02-11       Impact factor: 6.384

9.  Epigenome-Wide Association Study of Prostate Cancer in African Americans Identifies DNA Methylation Biomarkers for Aggressive Disease.

Authors:  Yifan Xu; Chia-Wen Tsai; Wen-Shin Chang; Yuyan Han; Maosheng Huang; Curtis A Pettaway; Da-Tian Bau; Jian Gu
Journal:  Biomolecules       Date:  2021-12-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.